Cargando…

Diagnostic strategy of SARS-CoV-2 for containment under China's zero-COVID-19 policy

Detalles Bibliográficos
Autores principales:	Wan, Zhenzhou, Lu, Renfei, Zhao, Yongjuan, Zhang, Chiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056992/ https://www.ncbi.nlm.nih.gov/pubmed/35508273 http://dx.doi.org/10.1016/j.jinf.2022.04.044

Ejemplares similares

Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2
por: Lu, Renfei, et al.
Publicado: (2020)

Rapid detection of monkeypox virus and monkey B virus by a multiplex loop-mediated isothermal amplification assay
por: Zeng, Yi, et al.
Publicado: (2023)

Genomic surveillance of SARS-CoV-2 in mainland China after ending the zero-COVID policy, December 2022–January 2023
por: Liu, Pengcheng, et al.
Publicado: (2023)

Multiplex, Real-Time, Point-of-care RT-LAMP for SARS-CoV-2 Detection Using the HFman Probe
por: Dong, Yajuan, et al.
Publicado: (2022)

A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2
por: Lu, Renfei, et al.
Publicado: (2020)

Correction to: Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2
por: Lu, Renfei, et al.
Publicado: (2020)

China's ‘dynamic zero COVID-19 strategy’ will face greater challenges in the future
por: Cai, Juncheng, et al.
Publicado: (2022)

Comparative evaluation of 19 reverse transcription loop-mediated isothermal amplification assays for detection of SARS-CoV-2
por: Dong, Yajuan, et al.
Publicado: (2021)

The effect of implementing “medicines zero mark-up policy” in Beijing community health facilities
por: Cheng, Wei, et al.
Publicado: (2012)

Antimicrobial stewardship in non-COVID-19 patients with fever and respiratory symptoms in outpatient settings: Lessons from the "dynamic zero-COVID policy" in mainland China
por: Yang, Gang, et al.
Publicado: (2022)

Trump’s Zero-tolerance Policy: Would a Political Response to a Humanitarian Crisis Work?
por: Karamouzian, Mohammad
Publicado: (2018)

Mask-off policy in the shadow of emerging variants of SARS-COV-2
por: Shahraki, Abdolrazagh Hashemi, et al.
Publicado: (2021)

Zero-Tolerance Policy: The Last Way to Curb Workplace Violence against Nurses in Iranian Healthcare System
por: Hassankhani, Hadi, et al.
Publicado: (2017)

Solidifying diagnostics in SARS-CoV-2 research
por: Cimolai, Nevio
Publicado: (2022)

Surgical Strategies in the Era of SARS-CoV-2
por: Dimitroulis, Dimitrios, et al.
Publicado: (2020)

Cost-effectiveness analysis of COVID-19 screening strategy under China's dynamic zero-case policy
por: Li, Haonan, et al.
Publicado: (2023)

SARS-CoV-2 diagnostic testing in Africa: needs and challenges
por: Adebisi, Yusuff Adebayo, et al.
Publicado: (2020)

Strengths and weaknesses of the diagnostic tests for SARS-CoV-2 infection()
por: Hernández-Pérez, José María, et al.
Publicado: (2020)

Reliability of SARS-CoV-2 serological testing for influencing public health policies: A reappraisal
por: Lippi, Giuseppe, et al.
Publicado: (2023)

Different SARS-CoV-2 variants, same prevention strategies
por: Dzinamarira, Tafadzwa, et al.
Publicado: (2021)

Serosurvey of SARS-CoV-2 among hospital visitors in China
por: Liang, Wenhua, et al.
Publicado: (2020)

SARS-CoV-2: “Three-steps” infection model and CSF diagnostic implication
por: Panciani, Pier Paolo, et al.
Publicado: (2020)

Realistic considerations for comparison between SARS-CoV-2 molecular diagnostic assays
por: Poon, Kok-Siong, et al.
Publicado: (2021)

Effect of varying storage conditions on diagnostic test outcomes of SARS-CoV-2
por: Oguri, Satoshi, et al.
Publicado: (2021)

Seropositivity for SARS-CoV-2 in a General Population: How Specific Is the Diagnostic?
por: Lyu, Zhaoqing, et al.
Publicado: (2023)

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
por: Yoon, Jin Gu, et al.
Publicado: (2022)

Patterns of HIV and SARS‐CoV‐2 co‐infection in Wuhan, China
por: Guo, Wei, et al.
Publicado: (2020)

Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China
por: Akhmetzhanov, Andrei R.
Publicado: (2020)

Optimizing the dynamic zero-COVID policy in China
por: Bai, Wei, et al.
Publicado: (2022)

Saliva sampling for chasing SARS-CoV-2: A Game-changing strategy
por: Borghi, Elisa, et al.
Publicado: (2021)

The Strategy Management of a SARS-CoV-2 Outbreak in An Eastern European Hospital
por: Droc, Gabriela, et al.
Publicado: (2021)

Safety considerations for the use of Point‐Of‐Care diagnostics during SARS‐CoV‐2 pandemic
por: Raimann, Florian J., et al.
Publicado: (2020)

Applications of clear Dx whole genome sequencing system in SARS-CoV-2 diagnostics
por: Abdullah, Khansaa, et al.
Publicado: (2022)

Mallampati class ‘zero’ - yet another cause?
por: Indira, G
Publicado: (2011)

Use of proseal™ LMA in mallampati class zero
por: Chiplonkar, Sheetal, et al.
Publicado: (2012)

“Zero Tolerance” for disruptive health work behaviors
por: Tartaglia, Alexsandro
Publicado: (2019)

Positive Predictive Value of SARS-CoV-2 Spike Protein Antibody Test after COVID-19 Vaccination Policies
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Performance of COVIDSeq and Swift Normalase Amplicon SARS-CoV-2 Panels for SARS-CoV-2 Genome Sequencing: Practical Guide and Combining FASTQ Strategy
por: Choi, Hosoon, et al.
Publicado: (2022)

Do Long-Term Care Facilities Pursue a Zero COVID-19 Strategy while the Rest of Society Opens Up?
por: Tan, Li Feng, et al.
Publicado: (2022)

SARS-CoV-2 and Plasmodium falciparum are probably adopting Analogous strategy to invade erythrocytes
por: Konozy, Emadeldin H.E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2oeah4p8na4133i42gus02qnud